Get started
Author

H De Los Santos

Observed names: Heidi De Los Santos, Heidi DelosSantos Real
Observed institution: Merck, S.L.U. (Spain)
ORCID: 0000-0002-4630-2376
Observed ORCID: 0000-0002-4630-2376
OpenAlex ID: A5067569293
Cost–effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain
2023 · Ricardo Ginestal, Carlos Rubio-Terrés, et al. · Journal of Comparative Effectiveness Research · 2
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis
2026 · Celia Oreja-Guevara, Lamberto Landete, et al. · Journal of Medical Economics
PDF
EE586 Cost-Utility of Cladribine Tablets and Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis From the Societal Perspective in Spain
2022 · R Ginestal, O Duran, et al. · Value in Health
PDF
EE149 Cost-Effectiveness of Cladribine Tablets and Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis in Spain
2022 · R Ginestal, O Duran, et al. · Value in Health
Works count: 4
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type